Mark Houston
Index: J. Clin. Hypertens. (Greenwich.) 14(2) , 121-32, (2012)
Full Text: HTML
The combination of a lipid-lowering diet and scientifically proven nutraceutical supplements has the ability to significantly reduce low-density lipoprotein (LDL) cholesterol, increase LDL particle size, decrease LDL particle number, lower trigylcerides and very LDL levels, and increase total and high-density lipoprotein 2b cholesterol. In addition, inflammation, oxidative stress, and immune responses are decreased. In several prospective clinical trials, coronary heart disease and cardiovascular disease have been reduced with many nutraceutical supplements. This nutritional and nutraceutical supplement treatment is a valid alternative for patients who are intolerant to statins, cannot take other drugs for the treatment of dyslipidemia, or prefer alternative treatments. This new approach to lipid management to decrease vascular disease utilizes a functional medicine approach with a broader treatment program that will address the multitude of steps involved in lipid-induced vascular damage.© 2012 Wiley Periodicals, Inc.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
D-pantethine anhydrous
CAS:16816-67-4 |
C22H42N4O8S2 |
|
Variation in pantothenate kinase type determines the pantoth...
2014-10-01 [FEBS J. 281(20) , 4731-53, (2014)] |
|
Pantethine treatment is effective in recovering the disease ...
2014-01-01 [Brain 137(Pt 1) , 57-68, (2014)] |
|
Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity...
2010-01-01 [BMC Neurosci. 11 , 51, (2010)] |
|
The STM4195 gene product (PanS) transports coenzyme A precur...
2015-04-01 [J. Bacteriol. 197(8) , 1368-77, (2015)] |
|
Can drugs or micronutrients prevent cataract?
2001-01-01 [Drugs Aging 18(7) , 473-86, (2001)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
